Brief: Taro Pharmaceutical Industries Reports Q3 Sales Of $176.4 Mln

Taro Pharmaceutical Industries

07/02/2019 24:23

Feb 6 (Reuters) - Taro Pharmaceutical Industries Ltd
 TARO.N :
    * Q3 EARNINGS PER SHARE $2.40
    * Q3 SALES $176.4 MILLION
    * TARO PHARMACEUTICAL INDUSTRIES  - BOARD OF DIRECTORS
APPROVED
COMPANY TO DISCONTINUE PROMOTION OF ITS U.S. BRANDED PRODUCTS
EFFECTIVE MARCH 31, 2019
    * MOVE TO DISCONTINUE PROMOTION OF U.S. BRANDED PRODUCTS
EXPECTED
TO HAVE  IMMATERIAL IMPACT ON NET SALES OF CO

Source text for Eikon:  ID:nBw9b42kja 
Further company coverage:  TARO.N 

 ((Reuters.Briefs@thomsonreuters.com;))